OREXIGEN THERAPEUTICS INC's ticker is OREXXXXX and the CUSIP is 686164104. A total of 1 filers reported holding OREXIGEN THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $0 | -100.0% | 859 | -3.8% | 0.00% | – |
| Q1 2016 | $1,000 | 0.0% | 893 | +3.6% | 0.00% | – |
| Q4 2015 | $1,000 | -85.7% | 862 | -74.6% | 0.00% | – |
| Q3 2015 | $7,000 | -58.8% | 3,398 | +0.9% | 0.00% | – |
| Q2 2015 | $17,000 | -22.7% | 3,369 | +20.1% | 0.00% | – |
| Q1 2015 | $22,000 | +37.5% | 2,804 | +4.4% | 0.00% | – |
| Q4 2014 | $16,000 | +45.5% | 2,685 | 0.0% | 0.00% | – |
| Q3 2014 | $11,000 | -35.3% | 2,685 | 0.0% | 0.00% | – |
| Q2 2014 | $17,000 | 0.0% | 2,685 | 0.0% | 0.00% | – |
| Q1 2014 | $17,000 | +30.8% | 2,685 | +14.2% | 0.00% | – |
| Q4 2013 | $13,000 | -7.1% | 2,351 | 0.0% | 0.00% | – |
| Q3 2013 | $14,000 | 0.0% | 2,351 | 0.0% | 0.00% | – |
| Q2 2013 | $14,000 | – | 2,351 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 5,427,559 | $2,334,000 | 1.60% |
| Scale Management, LLC | 1,312,575 | $564,000 | 1.34% |
| Foresite Capital Management III, LLC | 2,542,575 | $1,093,000 | 0.75% |
| BVF INC/IL | 5,252,100 | $2,258,000 | 0.48% |
| TIVERTON ASSET MANAGEMENT LLC | 45,313 | $4,261,000 | 0.18% |
| Baupost Group | 22,268,399 | $9,575,000 | 0.13% |
| Rhenman & Partners Asset Management AB | 1,200,000 | $516,000 | 0.09% |
| NEA Management Company, LLC | 370,900 | $1,595,000 | 0.08% |
| SAMLYN CAPITAL, LLC | 6,160,417 | $2,649,000 | 0.06% |
| Palo Alto Investors LP | 1,673,024 | $719,000 | 0.05% |